| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.00096 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.044 | 0.5 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.082 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.13 | 0.06 |